169 related articles for article (PubMed ID: 16128647)
21. Implanted intrathecal drug delivery systems and radiation treatment.
Gebhardt R; Ludwig M; Kirsner S; Kisling K; Kosturakis AK
Pain Med; 2013 Mar; 14(3):398-402. PubMed ID: 23432925
[TBL] [Abstract][Full Text] [Related]
22. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
Kongkam P; Wagner DL; Sherman S; Fogel EL; Whittaker SC; Watkins JL; McHenry L; Lehman GA
Am J Gastroenterol; 2009 May; 104(5):1249-55. PubMed ID: 19367269
[TBL] [Abstract][Full Text] [Related]
23. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
[TBL] [Abstract][Full Text] [Related]
24. Retrospective Analysis of Intrathecal Drug Delivery: Outcomes, Efficacy, and Risk for Cancer-Related Pain at a High Volume Academic Medical Center.
Sayed D; Monroe F; Orr WN; Phadnis M; Khan TW; Braun E; Manion S; Nicol A
Neuromodulation; 2018 Oct; 21(7):660-663. PubMed ID: 29446171
[TBL] [Abstract][Full Text] [Related]
25. Intrathecal morphine pump for neuropathic cancer pain: a case report.
Gogia V; Chaudhary P; Ahmed A; Khurana D; Mishra S; Bhatnagar S
Am J Hosp Palliat Care; 2012 Aug; 29(5):409-11. PubMed ID: 21868426
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness and Safety of Intrathecal Drug Delivery Systems for the Management of Cancer Pain: A Systematic Review and Meta-Analysis.
Duarte R; Copley S; Nevitt S; Maden M; Al-Ali AM; Dupoiron D; Eldabe S
Neuromodulation; 2023 Aug; 26(6):1126-1141. PubMed ID: 35422368
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function.
Odell DW; Albrechtsen RD; Sindt JE; Gole R; Brown S; Parsons MW; Paxton AB; Sarkar V; Lloyd S; Brogan SE; Tao R
Neuromodulation; 2021 Oct; 24(7):1204-1208. PubMed ID: 33624320
[TBL] [Abstract][Full Text] [Related]
28. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.
Rodriguez RF; Castillo JM; Del Pilar Castillo M; Nuñez PD; Rodriguez MF; Restrepo JM; Rodriguez JM; Ortiz Y; Angel AM
Clin Ther; 2007 Apr; 29(4):581-7. PubMed ID: 17617281
[TBL] [Abstract][Full Text] [Related]
29. More time in a community setting: A service evaluation of the impact of intrathecal drug delivery systems on place of care of patients with cancer pain.
Mitchell A; Somerville L; Williams N; McGhie J; McConnachie A; McGinn G; Lee J
Palliat Med; 2023 Oct; 37(9):1461-1466. PubMed ID: 37632373
[TBL] [Abstract][Full Text] [Related]
30. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
Duse G; Davià G; White PF
Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
[TBL] [Abstract][Full Text] [Related]
31. Rationale and Recent Advances in Targeted Drug Delivery for Cancer Pain: Is It Time to Change the Paradigm?
Dupoiron D; Duarte R; Carvajal G; Aubrun F; Eldabe S
Pain Physician; 2022 May; 25(3):E414-E425. PubMed ID: 35652767
[TBL] [Abstract][Full Text] [Related]
32. Successful Management of Corneal Neuropathic Pain with Intrathecal Targeted Drug Delivery.
Hayek SM; Sweet JA; Miller JP; Sayegh RR
Pain Med; 2016 Jul; 17(7):1302-7. PubMed ID: 26814286
[TBL] [Abstract][Full Text] [Related]
33. Surgical Site Infections in Cancer Patients with Intrathecal Drug Delivery Devices.
Scanlon MM; Gazelka HM; Moeschler SM; Hoelzer BC; Hooten WM; Bendel MA; Lamer TJ
Pain Med; 2017 Mar; 18(3):520-525. PubMed ID: 27550951
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of intrathecal bupivacaine: how important is the flow rate?
Buchser E; Durrer A; Chédel D; Mustaki JP
Pain Med; 2004 Sep; 5(3):248-52. PubMed ID: 15367302
[TBL] [Abstract][Full Text] [Related]
35. Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer.
Sindt JE; Odell DW; Dalley AP; Brogan SE
Neuromodulation; 2020 Oct; 23(7):978-983. PubMed ID: 32459393
[TBL] [Abstract][Full Text] [Related]
36. Intraspinal delivery of opiates by an implantable, programmable pump in patients with chronic, intractable pain of nonmalignant origin.
Kanoff RB
J Am Osteopath Assoc; 1994 Jun; 94(6):487-93. PubMed ID: 8077118
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry.
Stearns LM; Abd-Elsayed A; Perruchoud C; Spencer R; Hammond K; Stromberg K; Weaver T
Anesth Analg; 2020 Feb; 130(2):289-297. PubMed ID: 31567325
[TBL] [Abstract][Full Text] [Related]
38. Massive hydromorphone dose delivered subcutaneously instead of intrathecally: guidelines for prevention and management of opioid, local anesthetic, and clonidine overdose.
Coyne PJ; Hansen LA; Laird J; Buster P; Smith TJ
J Pain Symptom Manage; 2004 Sep; 28(3):273-6. PubMed ID: 15336340
[TBL] [Abstract][Full Text] [Related]
39. Managing intractable pain with an intrathecal catheter and injection port: technique and guidelines.
Meenan D; Lagares-Garcia JA; Kurek S; Craig D; Green J; Fritz W
Am Surg; 1999 Nov; 65(11):1054-60. PubMed ID: 10551756
[TBL] [Abstract][Full Text] [Related]
40. Programmable Pump for Intrathecal Morphine Delivery to Cisterna Magna: Clinical Implications in Novel Management of Refractory Pain Above Middle Thoracic Vertebrae Level Utilizing a Prospective Trial Protocol and Review.
Sun C; Wang YT; Dai YJ; Liu ZH; Yang J; Cheng ZQ; Dong DS; Wang CF; Zhao GL; Lu GJ; Song T; Jin Y; Kaye AD; Imani F; Sadegi K; Sun LL; Sun YH
Anesth Pain Med; 2021 Jun; 11(3):e115873. PubMed ID: 34540643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
